C9H13N3O5
243.22 g/mol
APIDanger
Cytarabine
CAS147-94-4EC205-705-9
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Cytarabine is a compound used in pharmaceutical manufacturing. It has been noted for potential developmental toxicity based on expert review.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 147-94-4
Related Compounds
StrongSame Parent
Cytarabine hydrochloride
CAS69-74-9
pharmaceutical raw material
SimilarStructure SimilarSimilarity 0.79
2'-fluoro-2'-deoxy-arabinofuranosyl-cytidine
CAS56632-83-8
research compound
SimilarStructure SimilarSimilarity 0.79
2'-fluoro-2'-deoxycytidine
CAS10212-20-1
pharmaceutical intermediate
ReferenceSame Category
[1-(2-Phenylethyl)-1h-imidazol-2-yl]-4-piperidinylmethanone dihydrobromide
CAS147064-11-7
pharmaceutical raw material
ReferenceSame Category
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-2-yl)methanone
CAS147082-78-8
pharmaceutical raw material
ReferenceSame Category
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine
CAS147083-36-1
pharmaceutical raw material
ReferenceSame Category
Alcaftadine carboxylic acid
CAS147083-93-0
pharmaceutical raw material
Referencestereoisomer of
5,6-dideuterio-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-iminopyrimidin-2-one
CAS40632-25-5
research compound
Safety Reference
Danger
H317May cause an allergic skin reaction
H340May cause genetic defects
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChIKey
UHDGCWIWMRVCDJ-CCXZUQQUSA-N
SMILES
C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
Synonyms (97)
- Citarabina [INN-Spanish]
- Cytarabine (JP18/USP/INN)
- Cytarabine, European Pharmacopoeia (EP)
- Cytarabine, United States Pharmacopeia (USP)
- Cytarabinum [INN-Latin]
- 1-Arabinofuranosylcytosine
- 1beta-D-Arabinosylcytosine
- Alexan
- Alexan 100
- Ara-C
- Ara-cell
- Arabine
- Arabinocytidine
- Arabinofuranosyl Cytidine
- Arabinofuranosylcytosine
- Arabinoside C
- Arabinoside, Cytosine
- Arabinosylcytosine
- Arabitin
- Aracytidine
- Aracytin
- Aracytine
- Arafcyt
- Beta-cytosine arabinoside
- CYTARABINE [MART.]
- Citarabina
- Cytarabin
- Cytarabina
- Cytarabine (Standard)
- Cytarabine - Bio-X trade mark
- Cytarabine CRS
- Cytarabine Impurity
- Cytarabine RS
- Cytarabinoside
- Cytarabinum
- Cytarbel
- Cytartbine
- Cytonal
- Cytosar
- Cytosar-U
- Cytosine arabinofuranoside
- Cytosine arabinose
- Cytosine arabinoside
- Cytosine arabinoside (VAN)
- Cytosine beta-D-arabinoside
- Cytosine-beta-arabinoside
- DepoCyte
- Depocyt
- Depocyt (TN)
- Depocyt (liposomal)
- Erpalfa
- Spongocytidine
- Starasid
- Tarabine
- Tarabine PFS
- U 19920A
- U-19,920
- Udicil
- VYXEOS COMPONENT CYTARABINE
- arabinocytosine
- beta Ara C
- beta-Arabinosylcytosine
- beta-D-Arabinosylcytosine
- cytarabine
- cytarabine liposome
- cytarabine liposome injection
- cytarabine ocphosphate